Geode Capital Management, LLC Beam Therapeutics Inc. Transaction History

Geode Capital Management, LLC

$1.24 Trillion
Q1 2025

A detailed history of Geode Capital Management, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,199,455 shares of BEAM stock, worth $39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,199,455

Previous 1,804,374 21.9%

Holding current value

$39 Million

Previous $44.7 Million 4.01%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$19.53 - $34.09 $7.72 Million - $13.5 Million	395,081 Added 21.9%	2,199,455 $43 Million
Q4 2024 Feb 12, 2025	SELL	$21.55 - $30.35 $71,308 - $100,428	-3,309 Reduced 0.18%	1,804,374 $44.7 Million
Q3 2024 Nov 12, 2024	BUY	$22.57 - $33.14 $1.76 Million - $2.59 Million	78,102 Added 4.52%	1,807,683 $44.3 Million
Q2 2024 Aug 09, 2024	BUY	$21.22 - $32.66 $1.97 Million - $3.03 Million	92,859 Added 5.67%	1,729,581 $40.5 Million
Q1 2024 May 13, 2024	BUY	$23.46 - $45.07 $1.44 Million - $2.77 Million	61,443 Added 3.9%	1,636,722 $54.1 Million
Q4 2023 Feb 13, 2024	BUY	$17.69 - $30.76 $1.88 Million - $3.28 Million	106,531 Added 7.25%	1,575,279 $42.9 Million
Q3 2023 Nov 13, 2023	BUY	$23.01 - $32.46 $3.33 Million - $4.69 Million	144,573 Added 10.92%	1,468,748 $35.3 Million
Q2 2023 Aug 11, 2023	BUY	$29.32 - $35.99 $3.57 Million - $4.39 Million	121,846 Added 10.13%	1,324,175 $42.3 Million
Q1 2023 May 15, 2023	BUY	$30.15 - $48.79 $1.49 Million - $2.41 Million	49,389 Added 4.28%	1,202,329 $36.8 Million
Q4 2022 Feb 13, 2023	BUY	$36.73 - $51.6 $1.78 Million - $2.5 Million	48,465 Added 4.39%	1,152,940 $45.1 Million
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $5.46 Million - $9.65 Million	137,252 Added 14.19%	1,104,475 $52.6 Million
Q2 2022 Aug 12, 2022	BUY	$29.86 - $62.36 $3.15 Million - $6.58 Million	105,529 Added 12.25%	967,223 $37.4 Million
Q1 2022 May 13, 2022	BUY	$53.73 - $82.16 $704,131 - $1.08 Million	13,105 Added 1.54%	861,694 $49.4 Million
Q4 2021 Feb 11, 2022	BUY	$68.02 - $99.06 $1.75 Million - $2.55 Million	25,695 Added 3.12%	848,589 $67.6 Million
Q3 2021 Nov 12, 2021	BUY	$84.37 - $133.6 $11.6 Million - $18.4 Million	137,620 Added 20.08%	822,894 $71.6 Million
Q2 2021 Aug 13, 2021	BUY	$64.12 - $128.71 $5.7 Million - $11.4 Million	88,869 Added 14.9%	685,274 $88.2 Million
Q1 2021 May 12, 2021	BUY	$71.28 - $120.75 $4.66 Million - $7.9 Million	65,440 Added 12.32%	596,405 $47.7 Million
Q4 2020 Feb 12, 2021	BUY	$22.24 - $95.63 $1.92 Million - $8.25 Million	86,275 Added 19.4%	530,965 $43.3 Million
Q3 2020 Nov 13, 2020	BUY	$19.0 - $30.57 $4.45 Million - $7.16 Million	234,161 Added 111.23%	444,690 $10.9 Million
Q2 2020 Aug 13, 2020	BUY	$15.26 - $28.66 $2.12 Million - $3.98 Million	138,963 Added 194.17%	210,529 $5.89 Million
Q1 2020 May 14, 2020	BUY	$13.31 - $29.2 $952,543 - $2.09 Million	71,566 New	71,566 $1.29 Million

Others Institutions Holding BEAM

# of Institutions

258

Shares Held

93.6M

Call Options Held

425K

Put Options Held

309K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.25B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Beam Therapeutics Inc. Transaction History